マイクロアレイの世界市場：市場規模・シェア・動向分析 (製品・サービス別、種類別、最終用途別、地域別)、セグメント別予測 (2025年～2030年)

マイクロアレイ市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のマイクロアレイの市場規模は2030年までに84億6,000万米ドルに達し、2025年から2030年までのCAGRは5.48％を記録すると予測されています。

市場促進要因としては、世界のがん患者の増加や、シーケンシング、ゲノムマッピング、個別化医療などにおけるマイクロアレイの幅広い応用が挙げられます。また、世界の研究開発投資の増加も、ヘルスケアの進歩・向上のための研究目的でのマイクロアレイ使用の増加につながるため、成長を促進する鍵となります。

マイクロアレイは、研究用途、創薬、疾病診断、ゲノム・プロテオーム研究、植物・食品研究、農業研究など、幅広い用途があります。米国神経学会が発表した報告書によると、染色体マイクロアレイ解析は知的障害やディスオミックの診断に使用でき、この検査は第一選択の診断検査としても推奨されています。最近のプロテオミクスとゲノミクスの進歩は、ヒトゲノムの塩基配列決定と相まって、スクリーニング可能な創薬標的を増加させています。PNAS（Proceedings of the National Academy of Sciences of the United States of America）に掲載された報告によると、ハイスループット毒性学的アッセイ用に小型3次元細胞培養マイクロアレイが開発されました。

主要企業がさまざまなタイプのアレイプラットフォームを導入していることも、市場の可能性を高めると予想される要因です。例えば、生物学的製品を扱う企業であるR&Dシステムズは、プロテオーム・プロファイラー抗体アレイを提供しており、これは1つのサンプルで119種類以上のタンパク質を測定するためのタンパク質マイクロアレイです。この製品を使用することで、ラボの技術者は特別な装置を必要とせず、さらにウェスタンブロット実験の必要性もなくなります。

近年、大規模な市場プレーヤーは、既存の製品ポートフォリオと地理的プレゼンスを拡大するために中小規模の企業と提携しています。例えば、2018年にMerckはHistoCyte Laboratories Ltd.と契約を締結し、米国およびその他の地域で細胞マイクロアレイを販売することで、研究者にコスト効率が高く簡単なオプションを提供します。

アジア太平洋地域は、主要企業によるマイクロアレイの承認取得の増加により、予測期間中に有利な成長が見込まれます。例えば、2015年、Agilent Technologies Inc.は、同社のSureScan Dxマイクロアレイスキャナについて中国FDAの認可を取得しました。中東・アフリカ地域も、病気の診断を改善するための新製品の発売により、絶大なビジネスチャンスを示すと予測されています。例えば、2017年、Thermo Fisher Scientific, Inc.は、Axiom Africaアレイを発売しました。このアレイは、アフリカの集団だけでなく、欧州やアジアの集団のゲノム全体の変異を捉えます。

マイクロアレイ市場レポートハイライト

• 2024年の市場シェアは、消耗品が49.73%で最大でした。分子診断や研究用途における自動化、高精度化、スケーラビリティへの要求の高まりにより、予測期間中は装置が最も速い速度で成長すると予測されます。
• DNAマイクロアレイは、2024年に最大の収益シェアを占めました。タンパク質マイクロアレイは、創薬、免疫プロファイリング、バイオマーカー検証での使用増加により、予測期間で最速成長が見込まれています。
• 2024年のマイクロアレイ市場は、ゲノミクス、プロテオミクス、バイオメディカルイノベーションへの投資の増加に支えられて、研究用途が支配的でした。疾病診断は、予測期間中に最も速い速度で成長すると予測されています。
• 2024年の市場収益シェアは、調査および学術機関が最大でした。診断ラボセグメントは予測期間中最も速いCAGRで成長すると予測されています。
• 北米のマイクロアレイ市場は世界産業を支配し、2024年には48.27%のシェアを占めました。アジア太平洋のマイクロアレイ市場は、研究開発活動への投資の増加によって、大きな成長が見込まれています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 マイクロアレイ市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• マイクロアレイ市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 マイクロアレイ市場：製品・サービス別の推定・動向分析

• 市場シェア：製品・サービス別（2023年・2030年）
• セグメントダッシュボード
• 世界のマイクロアレイ市場の展望：製品・サービス別
• 市場規模の予測と動向分析（2018～2030年）
  • 消耗品
  • 装置
  • ソフトウェア・サービス

第5章 マイクロアレイ市場：種類別の推定・動向分析

• 市場シェア：種類別（2023年・2030年）
• セグメントダッシュボード
• 世界のマイクロアレイ市場の展望：種類別
• 市場規模の予測と動向分析（2018～2030年）
  • DNAマイクロアレイ
  • タンパク質マイクロアレイ
  • その他

第6章 マイクロアレイ市場：用途別の推定・動向分析

• 市場シェア：用途別（2023年・2030年）
• セグメントダッシュボード
• 世界のマイクロアレイ市場の展望：用途別
• 市場規模の予測と動向分析（2018～2030年）
  • 研究用途
  • 創薬
  • 疾患診断
  • その他の用途

第7章 マイクロアレイ市場：最終用途別の推定・動向分析

• 市場シェア：最終用途別（2023年・2030年）
• セグメントダッシュボード
• 世界のマイクロアレイ市場の展望：最終用途別
• 市場規模の予測と動向分析（2018～2030年）
  • 研究・学術機関
  • 製薬・バイオテクノロジー企業
  • 診断検査室
  • その他

第8章 マイクロアレイ市場：地域別の推定・動向分析

• 市場シェア分析：地域別（2023年・2030年）
• 市場ダッシュボード：地域別
• 世界市場のスナップショット：地域別
• 市場規模の予測と動向分析（2018～2030年）
• 北米
  • 北米： SWOT分析
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州： SWOT分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • アジア太平洋： SWOT分析
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ラテンアメリカ： SWOT分析
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ：SWOT分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 最近の動向と影響分析：主な市場参入企業別
• 企業/競合の分類
• ベンダー情勢
  • 主要な流通業者・チャネルパートナーの一覧
  • 主要顧客
  • 主要企業の市場シェア分析 (2023年)
  • Thermo Fisher Scientific Inc（Applied Biosystems）
  • Agilent Technologies, Inc
  • Illumina, Inc
  • PerkinElmer
  • Schott（Applied Microarrays）
  • Danaher Corporation
  • Arrayit Corporation
  • Bio-Rad Laboratories, Inc
  • Microarrays Inc

List of Tables

• Table 1 List of abbreviation
• Table 2 North America microarray market, by region, 2018 - 2030 (USD Million)
• Table 3 North America microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 4 North America microarray market, by type, 2018 - 2030 (USD Million)
• Table 5 North America microarray market, by application, 2018 - 2030 (USD Million)
• Table 6 North America microarray market, by end use, 2018 - 2030 (USD Million)
• Table 7 U.S. microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 8 U.S. microarray market, by type, 2018 - 2030 (USD Million)
• Table 9 U.S. microarray market, by application, 2018 - 2030 (USD Million)
• Table 10 U.S. microarray market, by end use, 2018 - 2030 (USD Million)
• Table 11 Canada microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 12 Canada microarray market, by type, 2018 - 2030 (USD Million)
• Table 13 Canada microarray market, by application, 2018 - 2030 (USD Million)
• Table 14 Canada microarray market, by end use, 2018 - 2030 (USD Million)
• Table 15 Mexico microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 16 Mexico microarray market, by type, 2018 - 2030 (USD Million)
• Table 17 Mexico microarray market, by application, 2018 - 2030 (USD Million)
• Table 18 Mexico microarray market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe microarray market, by region, 2018 - 2030 (USD Million)
• Table 20 Europe microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 21 Europe microarray market, by type, 2018 - 2030 (USD Million)
• Table 22 Europe microarray market, by application, 2018 - 2030 (USD Million)
• Table 23 Europe microarray market, by end use, 2018 - 2030 (USD Million)
• Table 24 Germany microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 25 Germany microarray market, by type, 2018 - 2030 (USD Million)
• Table 26 Germany microarray market, by application, 2018 - 2030 (USD Million)
• Table 27 Germany microarray market, by end use, 2018 - 2030 (USD Million)
• Table 28 UK microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 29 UK microarray market, by type, 2018 - 2030 (USD Million)
• Table 30 UK microarray market, by application, 2018 - 2030 (USD Million)
• Table 31 UK microarray market, by end use, 2018 - 2030 (USD Million)
• Table 32 France microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 33 France microarray market, by type, 2018 - 2030 (USD Million)
• Table 34 France microarray market, by application, 2018 - 2030 (USD Million)
• Table 35 France microarray market, by end use, 2018 - 2030 (USD Million)
• Table 36 Italy microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 37 Italy microarray market, by type, 2018 - 2030 (USD Million)
• Table 38 Italy microarray market, by application, 2018 - 2030 (USD Million)
• Table 39 Italy microarray market, by end use, 2018 - 2030 (USD Million)
• Table 40 Spain microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 41 Spain microarray market, by type, 2018 - 2030 (USD Million)
• Table 42 Spain microarray market, by application, 2018 - 2030 (USD Million)
• Table 43 Spain microarray market, by end use, 2018 - 2030 (USD Million)
• Table 44 Denmark microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 45 Denmark microarray market, by type, 2018 - 2030 (USD Million)
• Table 46 Denmark microarray market, by application, 2018 - 2030 (USD Million)
• Table 47 Denmark microarray market, by end use, 2018 - 2030 (USD Million)
• Table 48 Sweden microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 49 Sweden microarray market, by type, 2018 - 2030 (USD Million)
• Table 50 Sweden microarray market, by application, 2018 - 2030 (USD Million)
• Table 51 Sweden microarray market, by end use, 2018 - 2030 (USD Million)
• Table 52 Norway microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 53 Norway microarray market, by type, 2018 - 2030 (USD Million)
• Table 54 Norway microarray market, by application, 2018 - 2030 (USD Million)
• Table 55 Norway microarray market, by end use, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific microarray market, by region, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific microarray market, by type, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific microarray market, by application, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific microarray market, by end use, 2018 - 2030 (USD Million)
• Table 61 China microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 62 China microarray market, by type, 2018 - 2030 (USD Million)
• Table 63 China microarray market, by application, 2018 - 2030 (USD Million)
• Table 64 China microarray market, by end use, 2018 - 2030 (USD Million)
• Table 65 Japan microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 66 Japan microarray market, by type, 2018 - 2030 (USD Million)
• Table 67 Japan microarray market, by application, 2018 - 2030 (USD Million)
• Table 68 Japan microarray market, by end use, 2018 - 2030 (USD Million)
• Table 69 India microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 70 India microarray market, by type, 2018 - 2030 (USD Million)
• Table 71 India microarray market, by application, 2018 - 2030 (USD Million)
• Table 72 India microarray market, by end use, 2018 - 2030 (USD Million)
• Table 73 South Korea microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 74 South Korea microarray market, by type, 2018 - 2030 (USD Million)
• Table 75 South Korea microarray market, by application, 2018 - 2030 (USD Million)
• Table 76 South Korea microarray market, by end use, 2018 - 2030 (USD Million)
• Table 77 Australia microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 78 Australia microarray market, by type, 2018 - 2030 (USD Million)
• Table 79 Australia microarray market, by application, 2018 - 2030 (USD Million)
• Table 80 Australia microarray market, by end use, 2018 - 2030 (USD Million)
• Table 81 Thailand microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 82 Thailand microarray market, by type, 2018 - 2030 (USD Million)
• Table 83 Thailand microarray market, by application, 2018 - 2030 (USD Million)
• Table 84 Thailand microarray market, by end use, 2018 - 2030 (USD Million)
• Table 85 Latin America microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 86 Latin America microarray market, by type, 2018 - 2030 (USD Million)
• Table 87 Latin America microarray market, by application, 2018 - 2030 (USD Million)
• Table 88 Latin America microarray market, by end use, 2018 - 2030 (USD Million)
• Table 89 Brazil microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 90 Brazil microarray market, by type, 2018 - 2030 (USD Million)
• Table 91 Brazil microarray market, by application, 2018 - 2030 (USD Million)
• Table 92 Brazil microarray market, by end use, 2018 - 2030 (USD Million)
• Table 93 Argentina microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 94 Argentina microarray market, by type, 2018 - 2030 (USD Million)
• Table 95 Argentina microarray market, by application, 2018 - 2030 (USD Million)
• Table 96 Argentina microarray market, by end use, 2018 - 2030 (USD Million)
• Table 97 MEA microarray market, by region, 2018 - 2030 (USD Million)
• Table 98 MEA microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 99 MEA microarray market, by type, 2018 - 2030 (USD Million)
• Table 100 MEA microarray market, by application, 2018 - 2030 (USD Million)
• Table 101 MEA microarray market, by end use, 2018 - 2030 (USD Million)
• Table 102 South Africa microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 103 South Africa microarray market, by type, 2018 - 2030 (USD Million)
• Table 104 South Africa microarray market, by application, 2018 - 2030 (USD Million)
• Table 105 South Africa microarray market, by end use, 2018 - 2030 (USD Million)
• Table 106 Saudi Arabia microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia microarray market, by type, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia microarray market, by application, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia microarray market, by end use, 2018 - 2030 (USD Million)
• Table 110 UAE microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 111 UAE microarray market, by type, 2018 - 2030 (USD Million)
• Table 112 UAE microarray market, by application, 2018 - 2030 (USD Million)
• Table 113 UAE microarray market, by end use, 2018 - 2030 (USD Million)
• Table 114 Kuwait microarray market, by product and services, 2018 - 2030 (USD Million)
• Table 115 Kuwait microarray market, by type, 2018 - 2030 (USD Million)
• Table 116 Kuwait microarray market, by application, 2018 - 2030 (USD Million)
• Table 117 Kuwait microarray market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Microarray: market outlook
• Fig. 14 Microarray competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook.
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Microarray driver impact
• Fig. 20 Microarray restraint impact
• Fig. 21 Microarray strategic initiatives analysis
• Fig. 22 Microarray: Product and Services movement analysis
• Fig. 23 Microarray: Product and Services outlook and key takeaways
• Fig. 24 Consumables market estimates and forecast, 2018 - 2030
• Fig. 25 Instruments market estimates and forecast, 2018 - 2030
• Fig. 26 Software and services market estimates and forecast, 2018 - 2030
• Fig. 27 Microarray: Type movement analysis
• Fig. 28 Microarray: Type outlook and key takeaways
• Fig. 29 DNA microarray market estimates and forecasts, 2018 - 2030
• Fig. 30 Protein microarray market estimates and forecasts,2018 - 2030
• Fig. 31 Others market estimates and forecasts,2018 - 2030
• Fig. 32 Microarray: Application movement analysis
• Fig. 33 Microarray: application outlook and key takeaways
• Fig. 34 Research applications market estimates and forecasts, 2018 - 2030
• Fig. 35 Drug discovery market estimates and forecasts, 2018 - 2030
• Fig. 36 Disease diagnostics market estimates and forecasts, 2018 - 2030
• Fig. 37 Others applications market estimates and forecasts, 2018 - 2030
• Fig. 38 Microarray: End use movement analysis
• Fig. 39 Microarray: End use outlook and key takeaways
• Fig. 40 Research and academic institutes market estimates and forecasts, 2018 - 2030
• Fig. 41 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 - 2030
• Fig. 42 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
• Fig. 43 Others market estimates and forecasts, 2018 - 2030
• Fig. 44 Global microarray market: Regional movement analysis
• Fig. 45 Global microarray market: Regional outlook and key takeaways
• Fig. 46 Global microarray market shares and leading players
• Fig. 47 North America
• Fig. 48 North America market estimates and forecasts, 2018 - 2030
• Fig. 49 U.S.
• Fig. 50 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 51 Canada
• Fig. 52 Canada market estimates and forecasts, 2018 - 2030
• Fig. 53 Mexico
• Fig. 54 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 55 Europe
• Fig. 56 Europe market estimates and forecasts, 2018 - 2030
• Fig. 57 UK
• Fig. 58 UK market estimates and forecasts, 2018 - 2030
• Fig. 59 Germany
• Fig. 60 Germany market estimates and forecasts, 2018 - 2030
• Fig. 61 France
• Fig. 62 France market estimates and forecasts, 2018 - 2030
• Fig. 63 Italy
• Fig. 64 Italy market estimates and forecasts, 2018 - 2030
• Fig. 65 Spain
• Fig. 66 Spain market estimates and forecasts, 2018 - 2030
• Fig. 67 Denmark
• Fig. 68 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 69 Sweden
• Fig. 70 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 71 Norway
• Fig. 72 Norway market estimates and forecasts, 2018 - 2030
• Fig. 73 Asia Pacific
• Fig. 74 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 75 China
• Fig. 76 China market estimates and forecasts, 2018 - 2030
• Fig. 77 Japan
• Fig. 78 Japan market estimates and forecasts, 2018 - 2030
• Fig. 79 India
• Fig. 80 India market estimates and forecasts, 2018 - 2030
• Fig. 81 Thailand
• Fig. 82 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 83 South Korea
• Fig. 84 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 85 Australia
• Fig. 86 Australia market estimates and forecasts, 2018 - 2030
• Fig. 87 Latin America
• Fig. 88 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 89 Brazil
• Fig. 90 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 91 Argentina
• Fig. 92 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 93 Middle East and Africa
• Fig. 94 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 95 South Africa
• Fig. 96 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 97 Saudi Arabia
• Fig. 98 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 99 UAE
• Fig. 100 UAE market estimates and forecasts, 2018 - 2030
• Fig. 101 Kuwait
• Fig. 102 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 103 Market share of key market players- Microarray

Microarray Market Growth & Trends:

The global microarray market size is expected to reach USD 8.46 billion by 2030, registering a CAGR of 5.48% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market drivers propelling market growth include a global rise in cancer cases and a wide range of applications of microarrays in sequencing, genome mapping, personalized medicines, and others. A rise in global R&D investments is also key in propelling growth as this would lead to a rise in the use of microarrays for research purposes to advance and improve in healthcare.

Microarrays have a wide range of applications such as research applications, drug discovery, disease diagnosis, genomic and proteomic research, plant and food research, agricultural research, among other applications. According to a report published by the American Academy of Neurology, chromosomal microarray analysis can be used to diagnose intellectual disabilities and disomic features, this test has also been recommended as a first line diagnostic test. Recent advances in proteomics and genomics coupled with human genome sequencing have led to an increase in several screenable drug targets. According to a report published by PNAS (Proceedings of the National Academy of Sciences of the United States of America), a miniature 3D cell culture microarray has been developed for high throughput toxicological assays.

The introduction of various types of array platforms offered by leading companies is also another factor anticipated to boost market potential. For instance, R&D Systems, a biological products company offers proteome profiler antibody array, a protein microarray used to measure over 119 proteins in one sample. With the use of this product, laboratory technicians do not need any specialized equipment additionally eliminating the need for western blot experiments.

In recent years, large scale market players have collaborated with small and medium scale companies to expand their existing product portfolio and geographical presence. For instance, in 2018, Merck signed an agreement with HistoCyte Laboratories Ltd., to distribute cell microarrays in the U.S. and other geographies thereby, facilitating researchers with a cost-effective and easy option.

The Asia Pacific region is expected to witness lucrative growth during the forecast period owing to rising regulatory approvals received by leading companies for microarrays. For instance, in 2015, Agilent Technologies Inc. received the China FDA approval for its SureScan Dx microarray scanner. The Middle East & African region is also anticipated to showcase immense opportunities due to the launch of new products in the region to improve the diagnosis of diseases. For instance, in 2017, Thermo Fisher Scientific, Inc. launched Axiom Africa array, this array captures genome-wide variation in African populations as well as in Europe and Asian populations.

Microarray Market Report Highlights:

• Consumables held the largest market share of 49.73% in 2024. Instruments are expected to grow at the fastest rate over the forecast period, driven by the increasing demand for automation, precision, and scalability in molecular diagnostics and research applications.
• DNA microarrays accounted for the largest revenue share in 2024. Protein microarrays are expected to grow at the fastest rate over the forecast period, owing to their increasing use in drug discovery, immune profiling, and biomarker validation.
• The research applications segment dominated the microarray market in 2024, supported by increasing investments in genomics, proteomics, and biomedical innovation. The disease diagnostics segment is anticipated to grow at the fastest rate over the forecast period.
• Research and academic institutes accounted for the largest revenue share of the market in 2024. The diagnostic laboratories segment is expected to grow at the fastest CAGR during the forecast period.
• North America microarray market dominated the global industry and accounted for a 48.27% share in 2024. The microarray market in Asia Pacific is anticipated to witness significant growth, driven by the increasing investment in research and development activities.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product and Services
  • 1.2.2. Type
  • 1.2.3. Application
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product and Services Outlook
  • 2.2.2. Type Outlook
  • 2.2.3. Application Outlook
  • 2.2.4. End Use Outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Microarray Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising demand for personalized medicine and genomic research
    • 3.2.1.2. Technological advancements in microarray platforms
    • 3.2.1.3. Expanding applications in diagnostics and infectious disease testing
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of microarray instruments and consumables
• 3.3. Microarray Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Microarray Market: Product and Services Estimates & Trend Analysis

• 4.1. Product and Services Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Microarray Market by Product and Services Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Consumables
    • 4.4.1.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Instruments
    • 4.4.2.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Software and Services
    • 4.4.3.1. Software and services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Microarray Market: Type Estimates & Trend Analysis

• 5.1. Type Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Microarray Market by Type Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. DNA Microarray
    • 5.4.1.1. DNA Microarray market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Protein Microarray
    • 5.4.2.1. Protein microarray market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Others
    • 5.4.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Microarray Market: Application Estimates & Trend Analysis

• 6.1. Application Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Microarray Market by Application Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Research applications
    • 6.4.1.1. Research application market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Drug discovery
    • 6.4.2.1. Drug discovery market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Disease diagnostics
    • 6.4.3.1. Disease diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Others applications
    • 6.4.4.1. Others application market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Microarray Market: End use Estimates & Trend Analysis

• 7.1. End use Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Microarray Market by End use Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4.1. Research and Academic Institutes
    • 7.4.1.1. Research and Academic Institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Pharmaceutical and Biotechnology Companies
    • 7.4.2.1. Pharmaceutical and Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Diagnostic Laboratories
    • 7.4.3.1. Diagnostic Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Others
    • 7.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Microarray Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. North America: SWOT Analysis
  • 8.5.2. U.S.
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. Europe: SWOT Analysis
  • 8.6.2. UK
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. Germany
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. France
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Norway
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.9. Denmark
    • 8.6.9.1. Key country dynamics
    • 8.6.9.2. Regulatory framework
    • 8.6.9.3. Competitive scenario
    • 8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Asia Pacific: SWOT Analysis
  • 8.7.2. Japan
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. China
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. India
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. Australia
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. South Korea
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.7. Thailand
    • 8.7.7.1. Key country dynamics
    • 8.7.7.2. Regulatory framework
    • 8.7.7.3. Competitive scenario
    • 8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Latin America: SWOT Analysis
  • 8.8.2. Brazil
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Argentina
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. MEA: SWOT Analysis
  • 8.9.2. South Africa
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. Saudi Arabia
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. UAE
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.5. Kuwait
    • 8.9.5.1. Key country dynamics
    • 8.9.5.2. Regulatory framework
    • 8.9.5.3. Competitive scenario
    • 8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2023
  • 9.3.4. Thermo Fisher Scientific Inc (Applied Biosystems)
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Services benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Agilent Technologies, Inc
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Services benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Illumina, Inc
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Services benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. PerkinElmer
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Services benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Schott (Applied Microarrays)
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Services benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Danaher Corporation
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Services benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Arrayit Corporation
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Services benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Bio-Rad Laboratories, Inc
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Services benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Microarrays Inc
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Services benchmarking
    • 9.3.12.4. Strategic initiatives